Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Non-Current Debt: 2015

Historic Non-Current Debt for KalVista Pharmaceuticals (KALV) over the last 1 years, with Dec 2015 value amounting to $3.2 million.

  • KalVista Pharmaceuticals' Non-Current Debt fell 20.65% to $2.7 million in Q1 2016 from the same period last year, while for Mar 2016 it was $2.7 million, marking a year-over-year decrease of 20.65%. This contributed to the annual value of $3.2 million for FY2015, which is N/A change from last year.
  • As of FY2015, KalVista Pharmaceuticals' Non-Current Debt stood at $3.2 million.
  • KalVista Pharmaceuticals' Non-Current Debt's 5-year high stood at $3.2 million during FY2015, with a 5-year trough of $3.2 million in FY2015.
  • For the 1-year period, KalVista Pharmaceuticals' Non-Current Debt averaged around $3.2 million, with its median value being $3.2 million (2015).